CEBPZ and acute myeloid leukemia: UK MRC trials group demonstrated that in CBF positive AML, MRD monitoring by RT-PCR at different time points identified patients at higher risk of relapse.9 However, using RT-PCR, persistent PCR positivity has been observed in long-term survivors even after allogeneic stem cell transplantation (ASCT).